Improving Rates of Pneumococcal Vaccination in a Skilled Nursing Facility

Author:

Helms Jonathan,Reinbeck Donna

Abstract

The pneumonia vaccine is the best way to prevent pneumococcal disease and the high cost of readmission for patients and payors. The readmission rate at a skilled nursing facility (SNF) for a patient with a diagnosis of pneumonia was 24%, whereas the vaccination rate at the SNF was only 28%. This finding is significant because patients aged ≥65 years have a 35% reduction in pneumonia influenzas and all-cause mortality with appropriate pneumococcal vaccination. The current initiative sought to increase the pneumococcal vaccine rate at a SNF through implementation of a structured vaccine initiative. After implementation of a pneumococcal vaccination bundle, vaccine uptake increased from 28% to 66%. The success of the pneumococcal vaccination bundle showed that a focused effort using context-specific, evidence-based interventions can increase vaccine uptake. Adapting an evidence-based bundle to fit the needs of the user's context is an important component to the success of vaccination initiatives. [ Journal of Gerontological Nursing, 48 (12), 52–56.]

Publisher

SLACK, Inc.

Subject

Gerontology,General Nursing

Reference21 articles.

1. Agency for Healthcare Research and Quality. (2020). National healthcare quality and disparities reports (NHQDR). https://nhqrnet.ahrq.gov/inhqrdr/National/benchmark/table/All_Measures/All_Topics#achieved

2. The relative burden of community-acquired pneumonia hospitalizations in older adults: a retrospective observational study in the United States

3. Centers for Disease Control and Prevention. (2021). Weekly updates by select demographic and geographic characteristics: Provisional death counts for coronavirus disease 2019 (COVID-19). https://www.cdc.gov/nchs/nvss/vsrr/covid_weekly/index.htm

4. Centers for Disease Control and Prevention. (2022a). Pneumococcal vaccine timing for adults. https://www.cdc.gov/vaccines/vpd/pneumo/downloads/pneumo-vaccine-timing.pdf

5. Centers for Disease Control and Prevention. (2022b). Use of COVID-19 vaccines in the United States: Interim clinical considerations. https://www.cdc.gov/vaccines/covid-19/clinical-considerations/covid-19-vaccinesus.html

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3